SS Innovations (NASDAQ: SSII) launches robotic cardiac surgery program at HCG Hospital in Ahmedabad using the SSi Mantra 3.0 system. With 238 units installed across 12 countries — up 42% — the company is pushing toward FDA and EU regulatory approval. #RoboticSurgery #MedTech

SS Innovations (NASDAQ: SSII) launches robotic cardiac surgery at HCG Hospital in Ahmedabad. With 238 SSi Mantra systems now installed across 12 countries — up 42% in 2026 — the company is also pursuing U.S. FDA review and EU CE marking. #RoboticSurgery #MedTech

SS Innovations (NASDAQ: SSII) reports a 143% surge in robotic procedures and 39% revenue growth in Q2 2026, with 224 systems across 12 countries and FDA review expected by Q1 2027. #SurgicalRobotics #MedTech

Avatar Medical and Kyber have secured €3.7M under France 2030 to develop Avatar MediVerse, bringing immersive 3D medical imaging across the full surgical care pathway — from consultation to the operating room. #MedTech #HealthcareInnovation

Viromed Medical AG secures EU MDR approval for ViroCAP med, launches sales, and confirms full-year guidance for significant revenue growth in 2026. Equity surged 43.9% to EUR 9.5M. #MedTech #ColdPlasma

Avatar Medical Vision can now launch directly from Epic EHR, giving clinicians instant access to patient-specific 3D anatomy during consultations and surgical planning. First live at UHealth - University of Miami Health System. #MedTech #DigitalHealth

SS Innovations (NASDAQ: SSII) reports Q2 revenue up 39.4% to $13.9M, with 224 surgical robotic systems now installed across 12 countries and 12,000+ procedures completed. U.S. FDA and EU approvals in pursuit. #RoboticSurgery #MedTech

HeartBeam (NASDAQ: BEAT) has received FDA Breakthrough Device Designation for at-home heart attack assessment using its 3D ECG technology. The FDA acted in 30 days, half the standard timeline. A pivotal study is planned for the coming months. #MedTech #CardiacCare